NeoGenomics NEO Return on invested capital

Return on invested capital at other companies

Myriad GeneticsMYGN

-65.7%-96.6pp

Labcorp HoldingsLH

10.3%+1.0pp

Quest DiagnosticsDGX

9.5%+0.3pp

Biodesix, Inc.BDSX

-39.8%-10.7pp

Personalis, Inc.PSNL

-51.5%+9.2pp

Guardant HealthGH

-132.8%—

FAQ

What is NeoGenomics's return on invested capital?

NeoGenomics (NEO) reported return on invested capital of -7.4% in Q2 2026.

How has NeoGenomics's return on invested capital changed year-over-year?

NeoGenomics's return on invested capital increased by 55.3% year-over-year, from -16.5% to -7.4%.

What is the long-term trend for NeoGenomics's return on invested capital?

Over 4 years (2021 to 2025), NeoGenomics's return on invested capital has grown at a -7.9% compound annual growth rate (CAGR), from -17.1% to -12.3%.

What does return on invested capital mean?

Net operating profit after tax (operating income taxed at the effective rate) divided by average invested capital (debt plus equity minus cash). Measures the after-tax return on all capital put to work in the business, independent of capital structure.